Bispecific Antibody Therapeutic Market Report

China Bispecific Antibody Therapeutic Industry Market Research Report 2023-2029

  • POSTDATE：Aug 24, 2023
  • PAGES：141
  • REPORT CODE：GMM1753085
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Bispecific antibodies (BsAbs) recognize two different epitopes. This dual specificity opens up a wide range of applications, including redirecting T cells to tumor cells, blocking two different signaling pathways simultaneously, dual targeting of different disease mediators, and delivering payloads to targeted sites. The approval of catumaxomab (anti-EpCAM and anti-CD3) and blinatumomab (anti-CD19 and anti-CD3) has become a major milestone in the development of bsAbs. Currently, more than 60 different bsAb formats exist, some of them making their way into the clinical pipeline. This review summarizes diverse formats of bsAbs and their clinical applications and sheds light on strategies to optimize the design of bsAbs.

    This report elaborates on the current development of the Bispecific Antibody Therapeutic industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • PharmAbcine

    • Sorrento Therapeutics

    • Patheon

    By Type:

    • Lacking An Fc Region

    • Bearing An Fc Region

    By Application:

    • Gene Therapy

    • Oncology

    • Pulmonary

    • Osteology

    • Respiratory Diseases

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Bispecific Antibody Therapeutic Market Overview 2018-2029

    • 1.1 China Bispecific Antibody Therapeutic Industry Development Overview

    • 1.2 China Bispecific Antibody Therapeutic Industry Development History

    • 1.3 China Bispecific Antibody Therapeutic Industry Market Size (2018-2029)

    • 1.4 China Bispecific Antibody Therapeutic Market Analysis by Type from Production Side

      • 1.4.1 China Bispecific Antibody Therapeutic Production Volume, Production Value and Growth Rate of Lacking An Fc Region (2018-2029)

      • 1.4.2 China Bispecific Antibody Therapeutic Production Volume, Production Value and Growth Rate of Bearing An Fc Region (2018-2029)

    • 1.5 China Bispecific Antibody Therapeutic Market Analysis by Application from Consumption End

      • 1.5.1 China Bispecific Antibody Therapeutic Sales Volume, Sales Value and Growth Rate of Gene Therapy (2018-2029)

      • 1.5.2 China Bispecific Antibody Therapeutic Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

      • 1.5.3 China Bispecific Antibody Therapeutic Sales Volume, Sales Value and Growth Rate of Pulmonary (2018-2029)

      • 1.5.4 China Bispecific Antibody Therapeutic Sales Volume, Sales Value and Growth Rate of Osteology (2018-2029)

      • 1.5.5 China Bispecific Antibody Therapeutic Sales Volume, Sales Value and Growth Rate of Respiratory Diseases (2018-2029)

    • 1.6 China Bispecific Antibody Therapeutic Market Analysis by Region

      • 1.6.1 North China Bispecific Antibody Therapeutic Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Bispecific Antibody Therapeutic Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Bispecific Antibody Therapeutic Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Bispecific Antibody Therapeutic Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Bispecific Antibody Therapeutic Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Bispecific Antibody Therapeutic Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Bispecific Antibody Therapeutic Market Size and Growth Rate from 2018-2029

    Chapter 2 China Bispecific Antibody Therapeutic Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Bispecific Antibody Therapeutic Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Bispecific Antibody Therapeutic Market Status and Competition Analysis in 2023

      • 2.2.3 China Bispecific Antibody Therapeutic Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Bispecific Antibody Therapeutic Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Bispecific Antibody Therapeutic Industry Development

    Chapter 3 Bispecific Antibody TherapeuticIndustry Chain Analysis

    • 3.1 Bispecific Antibody Therapeutic Industry Chain

    • 3.2 Bispecific Antibody Therapeutic Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Bispecific Antibody Therapeutic Market

    • 3.3 Bispecific Antibody Therapeutic Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Bispecific Antibody Therapeutic Market

    Chapter 4 China Bispecific Antibody Therapeutic Market, by Type

    • 4.1 China Bispecific Antibody Therapeutic Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Bispecific Antibody Therapeutic Total Production Volume and Growth Rate from Production Side

    • 4.5 China Bispecific Antibody Therapeutic Production Volume and Growth Rate, by Type

      • 4.5.1 China Bispecific Antibody Therapeutic Production Volume and Growth Rate of Lacking An Fc Region

      • 4.5.2 China Bispecific Antibody Therapeutic Production Volume and Growth Rate of Bearing An Fc Region

    Chapter 5 China Bispecific Antibody Therapeutic Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Bispecific Antibody Therapeutic Total Market Size and Growth Rate from Consumption End

    • 5.5 China Bispecific Antibody Therapeutic Market Size and Growth Rate, by Application

      • 5.5.1 China Bispecific Antibody Therapeutic Market Size and Growth Rate of Gene Therapy

      • 5.5.2 China Bispecific Antibody Therapeutic Market Size and Growth Rate of Oncology

      • 5.5.3 China Bispecific Antibody Therapeutic Market Size and Growth Rate of Pulmonary

      • 5.5.4 China Bispecific Antibody Therapeutic Market Size and Growth Rate of Osteology

      • 5.5.5 China Bispecific Antibody Therapeutic Market Size and Growth Rate of Respiratory Diseases

    Chapter 6 China Bispecific Antibody Therapeutic Market, by Region

    • 6.1 China Bispecific Antibody Therapeutic Production Volume and Production Value, by Region

    • 6.2 China Bispecific Antibody Therapeutic Sales Volume and Sales Value, by Region

    Chapter 7 North China Bispecific Antibody Therapeutic Market Analysis

    • 7.1 North China Bispecific Antibody Therapeutic Market, by Type

    • 7.2 North China Bispecific Antibody Therapeutic Market, by Application

    Chapter 8 Central China Bispecific Antibody Therapeutic Market Analysis

    • 8.1 Central China Bispecific Antibody Therapeutic Market, by Type

    • 8.2 Central China Bispecific Antibody Therapeutic Market, by Application

    Chapter 9 South China Bispecific Antibody Therapeutic Market Analysis

    • 9.1 South China Bispecific Antibody Therapeutic Market, by Type

    • 9.2 South China Bispecific Antibody Therapeutic Market, by Application

    Chapter 10 East China Bispecific Antibody Therapeutic Market Analysis

    • 10.1 East China Bispecific Antibody Therapeutic Market, by Type

    • 10.2 East China Bispecific Antibody Therapeutic Market, by Application

    Chapter 11 Northeast China Bispecific Antibody Therapeutic Market Analysis

    • 11.1 Northeast China Bispecific Antibody Therapeutic Market, by Type

    • 11.2 Northeast China Bispecific Antibody Therapeutic Market, by Application

    Chapter 12 Southwest China Bispecific Antibody Therapeutic Market Analysis

    • 12.1 Southwest China Bispecific Antibody Therapeutic Market, by Type

    • 12.2 Southwest China Bispecific Antibody Therapeutic Market, by Application

    Chapter 13 Northwest China Bispecific Antibody Therapeutic Market Analysis

    • 13.1 Northwest China Bispecific Antibody Therapeutic Market, by Type

    • 13.2 Northwest China Bispecific Antibody Therapeutic Market, by Application

    Chapter 14 Company Profiles

      • 14.1 PharmAbcine

        • 14.1.1 PharmAbcine Company Profile

        • 14.1.2 PharmAbcine Bispecific Antibody Therapeutic Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Sorrento Therapeutics

        • 14.2.1 Sorrento Therapeutics Company Profile

        • 14.2.2 Sorrento Therapeutics Bispecific Antibody Therapeutic Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Patheon

        • 14.3.1 Patheon Company Profile

        • 14.3.2 Patheon Bispecific Antibody Therapeutic Market Performance

        • 14.3.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Bispecific Antibody Therapeutic Industry Research Conclusions

    • 15.2 Bispecific Antibody Therapeutic Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Bispecific Antibody Therapeutic Industry Market Size (2018-2029)

    • Figure China Bispecific Antibody Therapeutic Production Volume, Production Value and Growth Rate of Lacking An Fc Region (2018-2029)

    • Figure China Bispecific Antibody Therapeutic Production Volume, Production Value and Growth Rate of Bearing An Fc Region (2018-2029)

    • Figure China Bispecific Antibody Therapeutic Sales Volume, Sales Value and Growth Rate of Gene Therapy (2018-2029)

    • Figure China Bispecific Antibody Therapeutic Sales Volume, Sales Value and Growth Rate of Oncology (2018-2029)

    • Figure China Bispecific Antibody Therapeutic Sales Volume, Sales Value and Growth Rate of Pulmonary (2018-2029)

    • Figure China Bispecific Antibody Therapeutic Sales Volume, Sales Value and Growth Rate of Osteology (2018-2029)

    • Figure China Bispecific Antibody Therapeutic Sales Volume, Sales Value and Growth Rate of Respiratory Diseases (2018-2029)

    • Figure North China Bispecific Antibody Therapeutic Market Size and Growth Rate from 2018-2029

    • Figure Central China Bispecific Antibody Therapeutic Market Size and Growth Rate from 2018-2029

    • Figure South China Bispecific Antibody Therapeutic Market Size and Growth Rate from 2018-2029

    • Figure East China Bispecific Antibody Therapeutic Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Bispecific Antibody Therapeutic Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Bispecific Antibody Therapeutic Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Bispecific Antibody Therapeutic Market Size and Growth Rate from 2018-2029

    • Figure Bispecific Antibody Therapeutic Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Bispecific Antibody Therapeutic Market Share by Type in 2018

    • Figure China Bispecific Antibody Therapeutic Market Share by Type in 2023

    • Figure China Bispecific Antibody Therapeutic Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Bispecific Antibody Therapeutic Production Volume and Growth Rate of Lacking An Fc Region (2018-2023)

    • Figure China Bispecific Antibody Therapeutic Production Volume and Growth Rate of Bearing An Fc Region (2018-2023)

    • Figure China Bispecific Antibody Therapeutic Market Share by Application in 2018

    • Figure China Bispecific Antibody Therapeutic Market Share by Application in 2023

    • Figure China Bispecific Antibody Therapeutic Total Market Size and Growth Rate from Consumption End

    • Figure China Bispecific Antibody Therapeutic Market Size and Growth Rate of Gene Therapy (2018-2023)

    • Figure China Bispecific Antibody Therapeutic Market Size and Growth Rate of Oncology (2018-2023)

    • Figure China Bispecific Antibody Therapeutic Market Size and Growth Rate of Pulmonary (2018-2023)

    • Figure China Bispecific Antibody Therapeutic Market Size and Growth Rate of Osteology (2018-2023)

    • Figure China Bispecific Antibody Therapeutic Market Size and Growth Rate of Respiratory Diseases (2018-2023)

    • Table China Bispecific Antibody Therapeutic Production Volume by Region (2018-2023)

    • Table China Bispecific Antibody Therapeutic Production Volume Share by Region (2018-2023)

    • Figure China Bispecific Antibody Therapeutic Production Volume Share by Region (2018-2023)

    • Table China Bispecific Antibody Therapeutic Production Value by Region (2018-2023)

    • Table China Bispecific Antibody Therapeutic Production Value Share by Region (2018-2023)

    • Figure China Bispecific Antibody Therapeutic Production Value Share by Region (2018-2023)

    • Table China Bispecific Antibody Therapeutic Sales Volume by Region (2018-2023)

    • Table China Bispecific Antibody Therapeutic Sales Volume Share by Region (2018-2023)

    • Figure China Bispecific Antibody Therapeutic Sales Volume Share by Region (2018-2023)

    • Table China Bispecific Antibody Therapeutic Sales Value by Region (2018-2023)

    • Table China Bispecific Antibody Therapeutic Sales Value Share by Region (2018-2023)

    • Figure China Bispecific Antibody Therapeutic Sales Value Share by Region (2018-2023)

    • Table North China Bispecific Antibody Therapeutic Production Volume by Type (2018-2023)

    • Table North China Bispecific Antibody Therapeutic Production Volume Share by Type (2018-2023)

    • Figure North China Bispecific Antibody Therapeutic Production Volume Share by Type (2018-2023)

    • Table North China Bispecific Antibody Therapeutic Sales Volume by Application (2018-2023)

    • Table North China Bispecific Antibody Therapeutic Sales Volume Share by Application (2018-2023)

    • Figure North China Bispecific Antibody Therapeutic Sales Volume Share by Application (2018-2023)

    • Table Central China Bispecific Antibody Therapeutic Production Volume by Type (2018-2023)

    • Table Central China Bispecific Antibody Therapeutic Production Volume Share by Type (2018-2023)

    • Figure Central China Bispecific Antibody Therapeutic Production Volume Share by Type (2018-2023)

    • Table Central China Bispecific Antibody Therapeutic Sales Volume by Application (2018-2023)

    • Table Central China Bispecific Antibody Therapeutic Sales Volume Share by Application (2018-2023)

    • Figure Central China Bispecific Antibody Therapeutic Sales Volume Share by Application (2018-2023)

    • Table South China Bispecific Antibody Therapeutic Production Volume by Type (2018-2023)

    • Table South China Bispecific Antibody Therapeutic Production Volume Share by Type (2018-2023)

    • Figure South China Bispecific Antibody Therapeutic Production Volume Share by Type (2018-2023)

    • Table South China Bispecific Antibody Therapeutic Sales Volume by Application (2018-2023)

    • Table South China Bispecific Antibody Therapeutic Sales Volume Share by Application (2018-2023)

    • Figure South China Bispecific Antibody Therapeutic Sales Volume Share by Application (2018-2023)

    • Table East China Bispecific Antibody Therapeutic Production Volume by Type (2018-2023)

    • Table East China Bispecific Antibody Therapeutic Production Volume Share by Type (2018-2023)

    • Figure East China Bispecific Antibody Therapeutic Production Volume Share by Type (2018-2023)

    • Table East China Bispecific Antibody Therapeutic Sales Volume by Application (2018-2023)

    • Table East China Bispecific Antibody Therapeutic Sales Volume Share by Application (2018-2023)

    • Figure East China Bispecific Antibody Therapeutic Sales Volume Share by Application (2018-2023)

    • Table Northeast China Bispecific Antibody Therapeutic Production Volume by Type (2018-2023)

    • Table Northeast China Bispecific Antibody Therapeutic Production Volume Share by Type (2018-2023)

    • Figure Northeast China Bispecific Antibody Therapeutic Production Volume Share by Type (2018-2023)

    • Table Northeast China Bispecific Antibody Therapeutic Sales Volume by Application (2018-2023)

    • Table Northeast China Bispecific Antibody Therapeutic Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Bispecific Antibody Therapeutic Sales Volume Share by Application (2018-2023)

    • Table Southwest China Bispecific Antibody Therapeutic Production Volume by Type (2018-2023)

    • Table Southwest China Bispecific Antibody Therapeutic Production Volume Share by Type (2018-2023)

    • Figure Southwest China Bispecific Antibody Therapeutic Production Volume Share by Type (2018-2023)

    • Table Southwest China Bispecific Antibody Therapeutic Sales Volume by Application (2018-2023)

    • Table Southwest China Bispecific Antibody Therapeutic Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Bispecific Antibody Therapeutic Sales Volume Share by Application (2018-2023)

    • Table Northwest China Bispecific Antibody Therapeutic Production Volume by Type (2018-2023)

    • Table Northwest China Bispecific Antibody Therapeutic Production Volume Share by Type (2018-2023)

    • Figure Northwest China Bispecific Antibody Therapeutic Production Volume Share by Type (2018-2023)

    • Table Northwest China Bispecific Antibody Therapeutic Sales Volume by Application (2018-2023)

    • Table Northwest China Bispecific Antibody Therapeutic Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Bispecific Antibody Therapeutic Sales Volume Share by Application (2018-2023)

    • Table PharmAbcine Company Profile

    • Table PharmAbcine Bispecific Antibody Therapeutic Revenue, Price and Gross (2018-2023)

    • Table Sorrento Therapeutics Company Profile

    • Table Sorrento Therapeutics Bispecific Antibody Therapeutic Revenue, Price and Gross (2018-2023)

    • Table Patheon Company Profile

    • Table Patheon Bispecific Antibody Therapeutic Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US